Huntington's Disease Trial, Recruiting NCT05808153 Sponsor: Assistance Publique - Hôpitaux de Paris Condition: Huntington's Disease
Back to Huntingtons Disease

Huntington's Disease Trial, Recruiting

NCT05808153
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You must be between 18 and 65 years old
  • You must be willing and able to give written consent to participate
  • You must be covered by a social security or health insurance plan
  • If you are a healthy volunteer (control group): You have no known genetic disease, no family history of Huntington's disease (HD), and your functional and movement scores fall within the normal range (confirm with trial site)
  • If you carry the HD gene and have symptoms (manifest carrier): You have 40 or more CAG repeats, a disease activity score of 250 or above, your functional ability is still relatively preserved, your symptoms started after age 20, and your diagnosis has been confirmed (confirm with trial site)
  • If you carry the HD gene but do not yet have symptoms (premanifest carrier): You have 40 or more CAG repeats, a disease activity score of 250 or above, and your functional and movement scores are within a specific range (confirm with trial site)
  • You must be physically able to sign the consent form yourself

Who may not be able to join:

  • People who are under legal guardianship or a court-appointed protection order
  • People who have a neurological or psychiatric condition that is not related to HD
  • People with another ongoing illness that could affect how they perform in the study
  • People with another long-term, progressive brain or nerve condition
  • People who have claustrophobia (fear of enclosed spaces, such as an MRI scanner)
  • People who have had a brain injury unrelated to HD
  • People with a pacemaker, implanted heart device, metal implants in or around the body, cochlear (ear) implants, neurostimulation devices, implanted drug pumps, or any other metal objects inside the body that could be unsafe during a brain scan (confirm with trial site)
  • People with metal fragments in their body such as bullets or shrapnel, certain types of aneurysm clips in the brain, or magnetic dental implants (confirm with trial site)
  • People with a known allergy or sensitivity to the radioactive tracer substance used in this study
  • Women who are pregnant or breastfeeding, or who plan to become pregnant during the study
  • People receiving state medical aid (confirm with trial site for local definition)
  • People who are currently imprisoned or otherwise deprived of their freedom
  • People who have taken part in another interventional clinical trial in the last 3 months, or who have ever participated in a trial involving neural transplants or gene therapy
  • People who have received a radioactive tracer injection as part of a research study in the last 12 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: (+33)1 49 81 23 10

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
21 March 2024
Est. completion
2 April 2025

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Genetic markers

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov